Jing Li

机构：Wannan Medical College, Ministry of Education of the People's Republic of China, Guangxi University, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming Medical University, Peking Union Medical College Hospital, National Clinical Research Center for Digestive Diseases, Shanxi Provincial Cancer Hospital, Shanghai Traditional Chinese Medicine Hospital · ORCID：0000-0003-2504-1629

发表论文 535 篇 · 总被引 10038 次 · h-index 45

代表论文

• First-line serplulimab plus chemotherapy with or without HLX04 versus chemotherapy in locally advanced or metastatic non-squamous non-small-cell lung cancer (ASTRUM-002): a randomised, double-blind, multicentre phase 3 trial (2025 · The Lancet Respiratory Medicine · 被引 7)
• Mycophenolate mofetil plus methotrexate versus cyclophosphamide with sequential azathioprine for treatment of Takayasu arteritis (2025 · Annals of the Rheumatic Diseases · 被引 6)
• Advances and challenges in Toll-like receptor-targeted therapy for rheumatoid arthritis (2025 · Drug Discovery Today · 被引 3)
• A randomised study examining the utility of lauromacrogol foam sclerotherapy vs pingyangmycin in treatment of pediatric lymphatic malformations --a single center report from China (2025 · Journal of Pediatric Surgery · 被引 3)
• Elevated novel inflammatory markers in heart failure patients are associated with increased risk of adverse outcomes within one year: insights from a longitudinal study (2025 · Frontiers in Cardiovascular Medicine · 被引 3)
• Mycophenolate Mofetil versus Cyclophosphamide for Initial Therapy in Childhood-Onset Proliferative Lupus Nephritis (2025 · Journal of the American Society of Nephrology · 被引 3)